Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a ...
Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...
It's dangerous in medicine to make decisions based solely on what makes intuitive sense. At the European Society of Cardiology (ESC) Congress 2023, we learned from the BUDAPEST CRT trial that the ...
The survival benefit of a cardiac resynchronization therapy-defibrillator (CRT-D) lasts for several years in patients with mild-to-moderate symptoms of heart failure (HF), a reduced ejection fraction, ...
SILVER SPRING, MD — Women, compared with men, showed improved survival from cardiac resynchronization therapy (CRT) across a wider range of prolonged QRS durations, a key factor in guidelines-based ...
In a large population of Medicare beneficiaries with heart failure who underwent implantation of a cardiac resynchronization therapy defibrillator, patients who had the cardiac characteristics of left ...
Please provide your email address to receive an email when new articles are posted on . Among patients with nonischemic cardiomyopathy, women were less likely to die or have a ventricular event than ...
AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...
CRT is a surgical procedure in which doctors implant a pacemaker in both the right and left sides of the heart to help your heart’s chambers beat together. The goal is to improve heart pumping ...
Medtronic announced Friday that FDA has approved the the first MR-conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure in the U.S. The Medtronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results